Skip to main content

Table 7 Independent predictors of 30-day death in the statin previous users subset of patients with clinically suspected VAP

From: Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study

 

Adjusted hazard ratio

95% CI

P

Age

1.06

1.02-1.11

<0.01

SOFA day-1

1.16

1.03-1.32

0.02

Statin continuation after ICU admission

0.47

0.22-0.97

0.04

  1. VAP, ventilator-associated pneumonia; CI, confidence interval; SOFA, sequential organ failure assessment; ICU, intensive care unit.
Back to article page

Critical Care

ISSN: 1364-8535